Výsledky vyhledávání

Young Investigator Award Session - Heart40Targeting the miRNA-106b-25 cluster as a potential regenerative therapeutic approach for myocardial injury41An allogeneic bioengineered myocardial graft limits infarct size and improves cardiac function: pre-clinical study in the porcine myocardial infarction model42Phosphoinositide 3-kinase gamma inhibition protects against anthracycline-induced cardiomyopathy by boosting cardiac autophagy43Functional screening of microRNAs identifies miR-22 as a regulator of cardiac autophagy and aging44Functional defects and molecular mechanisms of left ventricular non-compaction in nkx2.5 mutant mice45PITX2 modulates atrial membrane potential, potentiating the antiarrhythmic effects of sodium channel blockers

Autor: F Syeda, THM Nguyen, S K Gupta, MC Li, I Perea Gil, E Dirkx, A Raso, L Braga, L Zentilin, S Zacchigna, M Giacca, LJ De Windt, C Prat-Vidal, C Galvez-Monton, S Roura, A Llucia-Valldeperas, C Soler-Botija, I Diaz-Guemes, V Crisostomo, FM Sanchez-Margallo, A Bayes-Genis, J Cimino, MC De Santis, N Pianca, S Sciarretta, M Sandri, T Zaglia, M Mongillo, E Hirsch, A Ghigo, C Bauters, P De Groote, A Foinquinos, R Boon, S Batkai, F Pinet, T Thum, C Choquet, F Kober, M Bernard, RG Kelly, L Miquerol, N Lalevee, A Holmes, T Yu, S Tull, S Kuhlmann, D Pavlovic, D Betney, G Riley, JP Kucera, F Jousset, J De Groot, S Rohr, N Brown, L Fabritz, P Kirchhof

Publikováno v: Cardiovascular Research. 111:S8-S9

La LVNC est une cardiomyopathie rare, caracterisee par une hypertrabeculation et de profonds replis du ventricule gauche. A ce jour, nous ne savons toujours pas si la LVNC resulte d'un defaut se produisant durant le developpement cardiaque et si sa g

Vyhledávací nástroje:

Upřesnit hledání